he heart is a metabolic omnivore that requires use of a plethora of substrates, not only to meet energetic demands for continual contraction, but also to provide necessary building blocks for turnover of cellular constituents and synthesis of metabolically derived signaling species (1). A key concept for cardiac metabolism centers around the need for homeostasis (i.e., maintenance of processes within a discrete physiological range) in the face of perpetual fluctuations in environmental stimuli and/or stresses. This is achieved through metabolic flexibility, which in essence affords a buffering capacity. A simple example involves perturbations that occur over the course of the day; sleep and/or wake and fasting and/or feeding cycles result in daily fluctuations in energetic demand and nutrient availability, as well as a host of additional neurohumoral factors that are met by reciprocal oscillations in cardiac metabolism (2). During cardiac disease states, the heart is often described as metabolically inflexible, typically being suspended at extremities (i.e., chronic activation or repression, depending upon the pathology and metabolic parameter), coupled with an inability to appropriately respond to physiological challenges (3). This is exemplified by heart failure. The failing human heart has been described as an engine without fuel, due to severe metabolic impairments and an inability to generate sufficient adenosine triphosphate (ATP) for maintenance of contractile performance (4). Dysfunction of mitochondria (the primary site of ATP synthesis via oxidative phosphorylation) appears to be central to this pathology (4). Consistent with this idea, numerous studies suggest that myocardial oxidation of both glucose and fatty acids (major substrates for the heart) are reduced during heart failure. This is despite observations that circulating levels of these substrates are often elevated (5), which potentially leads to an imbalance between carbon availability and use. 
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Glucose serves as a good example. During heart failure, diminished glucose oxidation occurs concomitantly with accelerated glucose uptake and glycolytic flux (4, 5) . This uncoupling of glycolysis from glucose oxidation is associated with accumulation of lactate and protons; the latter decreases cardiac efficiency, in part, through augmented ATPdependent ion homeostasis required for proton extrusion from the cardiomyocyte (6) . Uncoupling of glycolysis from glucose oxidation has been reported during other pathological states, including diabetes mellitus and acute ischemia and/or reperfusion (7, 8) .
Multiple groups have reasoned that targeting metabolic derangements during heart failure has the therapeutic potential to improve cardiac function.
The uncoupling of glycolysis and glucose oxidation was targeted in the study by Wang et al. (9) Science author instructions page. E-mail: meyoung@uab.edu.
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